144 related articles for article (PubMed ID: 35971219)
1. Low Prevalence of Endoscopic Screening for Barrett's Esophagus in a Screening-Eligible Primary Care Population.
Eluri S; Reddy S; Ketchem CC; Tappata M; Nettles HG; Watts AE; Cotton CC; Dellon ES; Shaheen NJ
Am J Gastroenterol; 2022 Nov; 117(11):1764-1771. PubMed ID: 35971219
[TBL] [Abstract][Full Text] [Related]
2. Missed Opportunities for Screening and Surveillance of Barrett's Esophagus in Veterans with Esophageal Adenocarcinoma.
Hammad TA; Thrift AP; El-Serag HB; Husain NS
Dig Dis Sci; 2019 Feb; 64(2):367-372. PubMed ID: 30370493
[TBL] [Abstract][Full Text] [Related]
3. Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms.
Reavis KM; Morris CD; Gopal DV; Hunter JG; Jobe BA
Ann Surg; 2004 Jun; 239(6):849-56; discussion 856-8. PubMed ID: 15166964
[TBL] [Abstract][Full Text] [Related]
4. Gastroesophageal Reflux Disease Is Not a Great Screening Criterion: Time to Move on to Other Strategies for Controlling the Burden of Esophageal Adenocarcinoma.
Rubenstein JH
Am J Gastroenterol; 2022 Nov; 117(11):1759-1761. PubMed ID: 36327434
[TBL] [Abstract][Full Text] [Related]
5. Gastroesophageal reflux disease, proton-pump inhibitor use and Barrett's esophagus in esophageal adenocarcinoma: Trends revisited.
Lada MJ; Nieman DR; Han M; Timratana P; Alsalahi O; Peyre CG; Jones CE; Watson TJ; Peters JH
Surgery; 2013 Oct; 154(4):856-64; discussion 864-6. PubMed ID: 24074425
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and Predictors of Barrett's Esophagus After Negative Initial Endoscopy: Analysis From Two National Databases.
Dhaliwal L; Kamboj AK; Williams JL; Chandar AK; Sachdeva K; Gibbons E; Lansing R; Passe M; Perez JA; Avenir KLR; Martin SA; Leggett CL; Chak A; Falk GW; Wani S; Shaheen NJ; Kisiel JB; Iyer PG
Clin Gastroenterol Hepatol; 2024 Mar; 22(3):523-531.e3. PubMed ID: 37716614
[TBL] [Abstract][Full Text] [Related]
7. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
[TBL] [Abstract][Full Text] [Related]
8. LOW PREVALENCE OF BARRETT'S ESOPHAGUS IN A RISK AREA FOR ESOPHAGEAL CANCER IN SOUTH OF BRAZIL.
DE Carli DM; Araujo AF; Fagundes RB
Arq Gastroenterol; 2017 Dec; 54(4):305-307. PubMed ID: 28954045
[TBL] [Abstract][Full Text] [Related]
9. Missed Opportunities: the Timing and Frequency of Screening Colonoscopy in Patients That Develop Esophageal Adenocarcinoma.
McKay SC; DeSouza ML; Dunst CM; Reavis KM; Bradley DD; DeMeester SR
J Gastrointest Surg; 2023 Dec; 27(12):2711-2717. PubMed ID: 37932595
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of Barrett's Esophagus and Esophageal Adenocarcinoma With and Without Gastroesophageal Reflux: A Systematic Review and Meta-analysis.
Saha B; Vantanasiri K; Mohan BP; Goyal R; Garg N; Gerberi D; Kisiel JB; Singh S; Iyer PG
Clin Gastroenterol Hepatol; 2024 Jul; 22(7):1381-1394.e7. PubMed ID: 37879525
[TBL] [Abstract][Full Text] [Related]
11. Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review.
Shaheen N; Ransohoff DF
JAMA; 2002 Apr; 287(15):1972-81. PubMed ID: 11960540
[TBL] [Abstract][Full Text] [Related]
12. Gastroesophageal reflux disease and Barrett's esophagus after laparoscopic sleeve gastrectomy: a possible, underestimated long-term complication.
Genco A; Soricelli E; Casella G; Maselli R; Castagneto-Gissey L; Di Lorenzo N; Basso N
Surg Obes Relat Dis; 2017 Apr; 13(4):568-574. PubMed ID: 28089434
[TBL] [Abstract][Full Text] [Related]
13. Limitations of Heartburn and Other Societies' Criteria in Barrett's Screening for Detecting De Novo Esophageal Adenocarcinoma.
Sawas T; Zamani SA; Killcoyne S; Dullea A; Wang KK; Iyer PG; Fitzgerald RC; Katzka DA
Clin Gastroenterol Hepatol; 2022 Aug; 20(8):1709-1718. PubMed ID: 34757196
[TBL] [Abstract][Full Text] [Related]
14. Associations of diabetes mellitus, insulin, leptin, and ghrelin with gastroesophageal reflux and Barrett's esophagus.
Rubenstein JH; Morgenstern H; McConell D; Scheiman JM; Schoenfeld P; Appelman H; McMahon LF; Kao JY; Metko V; Zhang M; Inadomi JM
Gastroenterology; 2013 Dec; 145(6):1237-44.e1-5. PubMed ID: 23999171
[TBL] [Abstract][Full Text] [Related]
15. Screening for esophageal adenocarcinoma and precancerous conditions (dysplasia and Barrett's esophagus) in patients with chronic gastroesophageal reflux disease with or without other risk factors: two systematic reviews and one overview of reviews to inform a guideline of the Canadian Task Force on Preventive Health Care (CTFPHC).
Hamel C; Ahmadzai N; Beck A; Thuku M; Skidmore B; Pussegoda K; Bjerre L; Chatterjee A; Dennis K; Ferri L; Maziak DE; Shea BJ; Hutton B; Little J; Moher D; Stevens A
Syst Rev; 2020 Jan; 9(1):20. PubMed ID: 31996261
[TBL] [Abstract][Full Text] [Related]
16. Gastroesophageal reflux disease symptom severity, proton pump inhibitor use, and esophageal carcinogenesis.
Nason KS; Wichienkuer PP; Awais O; Schuchert MJ; Luketich JD; O'Rourke RW; Hunter JG; Morris CD; Jobe BA
Arch Surg; 2011 Jul; 146(7):851-8. PubMed ID: 21768433
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics of young patients with early Barrett's neoplasia.
Iwaya Y; Shimamura Y; Goda K; RodrÃguez de Santiago E; Coneys JG; Mosko JD; Kandel G; Kortan P; May G; Marcon N; Teshima C
World J Gastroenterol; 2019 Jun; 25(24):3069-3078. PubMed ID: 31293342
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of Barrett's esophagus in patients with or without GERD symptoms: role of race, age, and gender.
Fan X; Snyder N
Dig Dis Sci; 2009 Mar; 54(3):572-7. PubMed ID: 18654849
[TBL] [Abstract][Full Text] [Related]
19. Low Prevalence of Suspected Barrett's Esophagus in Patients With Gastroesophageal Reflux Disease Without Alarm Symptoms.
Lin EC; Holub J; Lieberman D; Hur C
Clin Gastroenterol Hepatol; 2019 Apr; 17(5):857-863. PubMed ID: 30196157
[TBL] [Abstract][Full Text] [Related]
20. Age at onset of GERD symptoms predicts risk of Barrett's esophagus.
Thrift AP; Kramer JR; Qureshi Z; Richardson PA; El-Serag HB
Am J Gastroenterol; 2013 Jun; 108(6):915-22. PubMed ID: 23567358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
